Michael Auerbach - 22 Jun 2021 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Reporting relationship: Director
Issuer ticker: ATAI
Reported as of: 22 Jun 2021
Net transaction value: +$69,990
SEC form: 4
Accepted by SEC: 24 Jun 2021, 16:15:31 UTC
Prior SEC filing: 17 Jun 2021
Next SEC filing: 13 Sep 2021
Source filing: View source filing
Reporting owner signature: /s/ Ryan Barrett, Attorney-in-fact

Key filing fact

Michael Auerbach filed Form 4 for ATAI Life Sciences N.V. (ATAI) on 24 Jun 2021.

Key facts

This page summarizes Michael Auerbach's Form 4 filing for ATAI Life Sciences N.V. (ATAI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 24 Jun 2021, 16:15.

Change

Previous filing in this sequence was filed on 17 Jun 2021.
Current net transaction value: +$69,990.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATAI transaction

Common Shares

Purchase

Transaction value: $69,990
Shares: +4,666
Change %: +0.08%
Price: $15.00^*
Shares after: 5,564,474
Date: 22 Jun 2021
Ownership: By Subversive Atai LLC
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Mr. Auerbach serves as General Partner of Subversive ATAI LLC, a multi-member limited liability company. Mr. Auerbach has sole voting and investment power with respect to the shares held by Subversive ATAI LLC.